PRICES OF 94 FORMULATION PACKS
REVISED/FIXED
The National Pharmaceutical
Pricing Authority has fixed/revised the prices of 94 formulation
packs on 9th July, 2003. The prices have been fixed
for the first time in the case of 12 formulation packs. In the
case of 75 packs the price has been revised downwards ranging
from 0.26% to 61.92%. The revision in prices was warranted due
to downward revision in the price of various scheduled bulk drugs.
There is no change of price in respect of 1 pack. In the case
of 6 packs the price has increased ranging from 0.10% to 17.87%
due to upward revision in the prices of raw materials.
Of the 94 formulation
packs, ceiling prices (exclusive of excise duty and local taxes
etc.) have been fixed in respect of 52 packs which are applicable
to all the manufacturers of all such formulations including SSI
Units. Non-ceiling prices (inclusive of excise duty but exclusive
of local taxes etc.) have been fixed in respect of 42 packs. The
prices have been fixed/revised in accordance with the provisions
of the Drugs Price Control Order (DPCO), 1995 and as per the established
criteria and guidelines. A copy of the statement showing the existing
and revised prices (where available) is enclosed herewith.
Prices have been
fixed/revised for Insulin-based formulation used in the treatment
of diabetics, Prednisolone-based formulations used as carticosteroids,
Erythromycin-based formulations used as Anti-biotic, Vitamin-based
formulations used in diseases caused by deficiency of vitamins,
Cefotaxime-based formulations used as anti-bacterial and Aspirin-based
formulations used as analgesic.
The prices fixed/revised
would become effective within 15 days from the date of notification
in the official gazette or the receipt of the order of the NPPA
in this behalf, as per Para 14(1) of DPCO, 1995. Necessary revised
price list is to be issued by the manufacturers/importers required
under sub-paragraph (3) of paragraph 14 of the DPCO, 1995. Accordingly,
as per the provision, the revised price list in Form-V of the
DPCO is to be furnished by the concerned manufacturer(s) to the
government and NPPA, State Drug Control Authorities and distributors,
wholesalers and retailers or any other agent.
The manufacturers
are also required to work out the pro-rata prices of different
pack sizes as the case may be, in terms of S.O. No. 83 (E) dated
27.01.98.
Click here for Statement
